Related Experiment Video
Updated: Feb 4, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
MiR-182 enhances radioresistance in non-small cell lung cancer cells by regulating FOXO3
Gang Chen1, Lina Yu1, Hui Dong1
1Department of Respiratory Medicine, People's Hospital of Haining, Haining, China.
Abstract:
Upregulated in lung cancer, miRNA-182 was found to be related to cancer proliferation and chemoresistance. However, there is no report on the role of miR-182 in radioresistance, which is a main obstacle of radiotherapy. In this study, we aim to depict the effect of miR-182 inhibition on cellular sensitivity to ionizing radiation. Our data confirm that miR-182 is upregulated in lung cancers and tissues and that miR-182 is responsive to irradiation. We also show that miR-182 knockdown suppresses cell proliferation and increases cell apoptosis after irradiation. DNA damage remains unrepaired in miR-182 knockdown cells, which results in cell cycle arrest. Finally, we find that FOXO3 is a direct target of miR-182 and that overexpression of FOXO3 enhances radiation resistance in miR-182 knockdown cells. In conclusion, our data suggest that miR-182 might account for radioresistance in lung cancer and that miR-182-FOXO3 provides a novel radiosensitizing target.
Insights
MicroRNA-182 (miRNA-182) promotes lung cancer radioresistance by inhibiting FOXO3. Inhibiting miRNA-182 enhances radiation sensitivity, offering a new target for lung cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- MicroRNA-182 (miRNA-182) is upregulated in lung cancer and linked to proliferation and chemoresistance.
- The role of miRNA-182 in radioresistance, a key challenge in radiotherapy, remains largely unexplored.
Purpose of the Study:
- To investigate the effect of miRNA-182 inhibition on lung cancer cell sensitivity to ionizing radiation.
- To elucidate the underlying molecular mechanisms of miRNA-182 in radioresistance.
Main Methods:
- Quantitative real-time PCR to assess miRNA-182 levels in lung cancer tissues and cell lines.
- MiRNA-182 knockdown using small interfering RNAs (siRNAs).
- Cell proliferation assays, apoptosis assays, and cell cycle analysis post-irradiation.
- Western blotting to detect protein expression, including FOXO3.
- Luciferase reporter assays to confirm direct targeting of FOXO3 by miRNA-182.
Main Results:
- MiRNA-182 is confirmed to be upregulated in lung cancer tissues and responsive to irradiation.
- MiRNA-182 knockdown significantly suppressed cell proliferation and increased apoptosis following irradiation.
- Cells with reduced miRNA-182 exhibited unrepaired DNA damage, leading to cell cycle arrest.
- FOXO3 was identified as a direct target of miRNA-182, and its overexpression reversed the radiosensitizing effect of miRNA-182 knockdown.
Conclusions:
- MiRNA-182 plays a crucial role in conferring radioresistance in lung cancer.
- The miRNA-182-FOXO3 axis represents a novel therapeutic target for overcoming radioresistance in lung cancer patients.
Related Concept Videos
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Regulation of Hematopoietic Stem Cells
Master Transcription Regulators
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
GTPases and their Regulation
Large G-proteins,...

